Stay updated with breaking news from Aiib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
About half of the jump in Part B premiums next year is due to the potential cost of covering Aduhelm, a drug targeting Alzheimer’s disease. Here’s why.
About half of the jump in Part B premiums next year is due to the potential cost of covering Aduhelm, a drug targeting Alzheimer’s disease. Here’s why.
Look underneath the surface of recent sell-offs and the fallout looked far worse than it seems, according to strategist Art Hogan.
Best Buy reaching its $90 breakout level would be an excellent buying opportunity, says Inside Edge Capital Management founder Todd Gordon.
Best Buy reaching its $90 breakout level would be an excellent buying opportunity, says Inside Edge Capital Management founder Todd Gordon.